Revenue Growth

This Under-The-Radar Pharmaceutical Sales Disruptor Is A Multi-Bagger Stock

“It’s a small cap, a billion-dollar company, 100% revenue growth, and it’s small and it’s unknown,” says the author of today’s article of the pharmaceutical marketing company he highlights, which is disrupting the way that drugs are traditionally sold to physicians – and has become a multi-bagger stock in the process. For more on this “under-the-radar pic for investors who…have… 

This Small Biotech Is Solving A Major (Non-COVID) Health Problem

While the small biotech company featured in today’s article is not working on solving the health problem of the day – COVID-19 – it is solving a major problem that affects one in eight couples and is more prevalent than diabetes, asthma and depression. And with the company having “a clear-cut mission, great management, and a history of revenue growth”,…